Mar 2021 $20 M No. 5 $10 to $50 million 13
CirrusMD Inc.: Raise no. 5, Mar 2021 × Investors in this round 13 investors had bought by the notice of Jun 22, 2021: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $20 M of $20 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andrew Altorfer · Executive Officer, Director, Promoter Gabe Varela · Executive Officer James C.T. Linfield · Executive Officer John Jepsen · Executive Officer, Promoter Wallace Blake Mckinney · Executive Officer Jeff Cook · Director Kelsey C.T. Maguire · Director Molly Bonakdarpour · Director Ryan Kirkpatrick · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Andrew Altorfer, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 22, 2021. Read the notice at the SEC .
equity SEC Feb 2019 $15 M No. 4 $10 to $50 million 37
CirrusMD Inc.: Raise no. 4, Feb 2019 × Investors in this round 37 investors had bought by the notice of May 2, 2019: 37 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $15 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andrew Christian Altorfer · Executive Officer, Director Gabe Blake Varela · Executive Officer M. Christian Saxman · Executive Officer Wallace Blake Mckinney · Executive Officer, Director Jeff Blake Cook · Director Ken Blake Hanover · Director Kyle Blake Williams · Director Molly Blake Mccartin · Director Ryan Blake Kirkpatrick · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by M. Christian Saxman, Chief Financial Officer. Source: SEC Form D, newest notice filed May 2, 2019. Read the notice at the SEC .
equity SEC Jun 2017 $7 M No. 3 $2 to $10 million 39
CirrusMD Inc.: Raise no. 3, Jun 2017 × Investors in this round 39 investors had bought by the notice of Jun 20, 2017: 39 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $7 M offered
Smallest investment taken $10,440
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andrew Altorfer · Executive Officer, Director · Co-Founder and Chief Executive Officer Christian Saxman · Executive Officer · Chief Financial Officer Wallace McKinney · Executive Officer, Director · Co-Founder and Chief Medical Officer Elliot Sands · Director Ken Hanover · Director Kyle Williams · Director Ryan Kirkpatrick · Director Sean Kearney · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Series A and A-1 Preferred Stock”Signed by Chris Saxman, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 20, 2017. Read the notice at the SEC .
equity SEC Mar 2016 $1 M No. 2 Under $2 million 20
CirrusMD Inc.: Raise no. 2, Mar 2016 × Investors in this round 20 investors had bought by the notice of Mar 15, 2016: 20 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered; $0 M still to sell
Smallest investment taken $5,555
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andrew Altorfer · Executive Officer, Director · Chief Executive Officer Chris Saxman · Executive Officer · Chief Operating Officer Elliot Sands · Director Jim Kasic · Director Ryan Kennedy · Director Wallace Mckinney · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by M. Christian Saxman, Chief Operating Officer. Source: SEC Form D, newest notice filed Mar 15, 2016. Read the notice at the SEC .
equity SEC Dec 2014 $2 M No. 1 Under $2 million 37
CirrusMD Inc.: Raise no. 1, Dec 2014 × Investors in this round 37 investors had bought by the notice of Jan 14, 2015: 37 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, securities to be acquired by exercising them, other: The offering consists of Series Seed Preferred Stock with previously issued convertible promissory notes converting into Series Seed Preferred Stock and Common Stock. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andrew Altorfer · Executive Officer, Director · Chief Executive Officer Chris Blake Saxman · Executive Officer · Chief Operating Officer Elliot Blake Sands · Director Wallace Blake McKinney · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The total offering amount includes the combined aggregate amounts of each of the Series Seed Preferred Stock and Common Stock.”Signed by M. Christian Saxman, Chief Operating Officer. Source: SEC Form D, newest notice filed Jan 14, 2015. Read the notice at the SEC .
equity SEC